Computed tomography, angiography and ultrasound in staging of renal carcinoma

ACR Appropriateness Criteria® Staging of Renal Cell Carcinoma: 2022 Update

Renal cell carcinoma is a complex group of highly heterogenous renal tumors demonstrating variable biological behavior. Pretreatment imaging of renal cell carcinoma involves accurate assessment of the primary tumor, presence of nodal, and distant metastases. CT and MRI are the key imaging modalities used in the staging of renal cell carcinoma. Important imaging features that impact treatment include tumor extension into renal sinus and perinephric fat, involvement of pelvicalyceal system, infiltration into adrenal gland, involvement of renal vein and inferior vena cava, as well as the presence of metastatic adenopathy and distant metastases. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision process support the systematic analysis of the medical literature from peer reviewed journals. Established methodology principles such as Grading of Recommendations Assessment, Development, and Evaluation or GRADE are adapted to evaluate the evidence. The RAND/UCLA Appropriateness Method User Manual provides the methodology to determine the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where peer reviewed literature is lacking or equivocal, experts may be the primary evidentiary source available to formulate a recommendation.

Clinical performance of ASAS Health Index in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: real-world evidence from Multicenter Nationwide Registry

The Assessment of SpondyloArthritis international Society Health Index (ASAS HI) is used as a new instrument in measuring the function, disability and health of patients with spondyloarthritis (SpA). However, the real-world evidence of ASAS HI is very limited. In the present study, our objective is to evaluate the psychometric properties and performance of ASAS HI in the real-world setting as well as comparing ASAS HI with the current instruments to assess the construct validity and determine the cut-off points in patients with both ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-axSpA). A total of 991 patients with axSpA who fulfilled either the ASAS classification criteria for axial SpA (axSpA) or the Modified New York Criteria (mNY) for AS were recruited from the Biologic and targeted Synthetic antirheumatic drugs Registry (BioStaR) SpA. The construct validity of ASAS HI against the Bath Ankylosing Spondylitis Disease Activities Index (BASDAI) and Ankylosing Spondylitis Disease Activity Score-C-Reactive Protein (ASDAS-CRP) the Bath Ankylosing Spondylitis Functional index (BASFI) was performed. Using the receiver operating characteristic (ROC) curves analysis, the cut-off points were calculated. Of all the recruited patients, 851 (85.9%) were AS and 140 (14.1%) were nr-axSpA. The difference in the mean ASAS HI scores of the patients with AS and the ones with nr-axSpA were not statistically significant (6.12 ± 4.29 and 6.42 ± 4.86, respectively). The mean ASAS HI score was significantly higher in females and small city residents. The ASAS HI had a strong construct validity against ASDAS-CRP, BASDAI and BASFI. A cut-off point of ≤ 4 was determined to discriminate good and moderate, as well as ≥ 12 to discriminate moderate and poor health status. In conclusion, ASAS HI is a reliable instrument to evaluate health and functioning for both patients with AS and nr-axSpA in clinical practice.

Long term survival in a young girl with renal cell carcinoma

A young girl with an uncommon renal tumour is the subject of this communication. A diagnosis of renal cell carcinoma was established post-operatively. Combined modality treatment including chemotherapy and radiotherapy has helped achieve a disease free survival of nearly 5 years.

CT staging of renal carcinoma: a prospective comparison of three dynamic computed tomography techniques

Three dynamic computed tomographic methods used for staging of renal carcinoma in 70 patients are described and compared. Twenty-eight patients were examined using incremental dynamic scanning across the kidneys whilst infusing contrast via an arm vein (technique 1). Eighteen patients were staged using a single location dynamic scan sequence at the level of the renal hilum followed by an incremental sequence during an infusion of contrast into the femoral vein (technique 2). Twenty-four patients were examined using a single location sequence at the level of the renal veins and a rapid bolus incremental dynamic technique (technique 3). Technique 1 correctly staged 20 patients (72%) with 4 patients (14%) understaged and 4 (14%) overstaged, technique 2 correctly staged 11 (61%) patients with 3 (17%) overstaged and 4 (22%) understaged and technique 3 staged 17 (71%) correctly with 3 (13%) understaged and 4 (17%) overstaged. The techniques using single location scanning were more accurate in demonstrating tumour involvement of the renal vein and inferior vena cava but were less accurate in assessing extracapsular spread. Technique 3 was the most accurate in the diagnosis of lymph-node involvement. As accurate pre-operative knowledge of vascular involvement by tumour is more important to the surgeon than the presence of extracapsular spread, the combined single location and incremental scan technique is advocated.

Staging of renal cell carcinoma by dynamic computed tomography: a prospective comparison of two techniques

Two dynamic computed tomographic methods used for staging renal carcinoma in 46 patients are described and compared. Twenty-eight patients were examined using an infusion technique during incremental dynamic scanning across the kidneys with contrast administered via an arm vein. Eighteen patients were staged using a technique comprising a single location dynamic scan sequence at the level of the renal hilum followed by an incremental sequence during an infusion of contrast into the femoral vein. When compared with overall pathological staging, the arm vein infusion technique correctly staged 20 patients (72%) with four patients (14%) understaged and four (14%) overstaged. The femoral vein infusion and single location dynamic scanning technique correctly staged 11 (61%) patients with three (17%) overstaged and four (22%) understaged. The femoral vein infusion with single location scanning was more accurate in demonstrating tumour involvement of the renal vein (83.3% correct vs. 78.6%), inferior vena cava (94.4% correct vs. 89.3%) and lymph nodes (88.9% correct vs. 78.6%) but was less accurate in assessing extracapsular spread (77.8% correct vs. 96.4%). The additional information obtained from the single location dynamic sequence is sufficiently valuable for this part of the second technique to be used in any scanning protocol for staging renal carcinoma.

A prospective study of the value of conventional CT, dynamic CT, ultrasonography and arteriography for staging renal carcinoma

The value of dynamic CT scanning for staging renal carcinoma was studied prospectively in 28 patients and the results compared with those of ultrasonography, arteriography and conventional CT. Arteriography correctly staged 48% of tumours; ultrasonography and conventional CT correctly staged 50% and dynamic CT correctly staged 72%. Dynamic CT staged renal carcinoma more accurately than ultrasonography, conventional CT or arteriography and it is suggested that arteriography should be restricted to specific indications such as the mapping of arterial anatomy and therapeutic renal artery embolisation.

Comparison of angiography and computed tomography using new morphologic criteria in staging of renal cell carcinoma

The staging of tumor extension, and regional lymph node and venous involvement by angiography and computed tomography (CT) using new morphologic criteria were compared with the surgical and histopathologic stage in 59 patients (60 cases) with renal cell carcinoma. A high degree of accuracy in staging of both angiography and CT was demonstrated. However, CT was more accurate and sensitive than angiography in the evaluation of tumor extension and regional lymph node involvement, and equally accurate in that of venous involvement. We emphasize that new morphologic criteria of angiography and CT are clinically useful, and CT is the primary approach for the staging of renal cell carcinoma.

Role of computed tomography in staging of renal cell carcinoma

Accurate pre-operative staging of renal cell carcinoma is necessary to determine the surgical approach and prognosis. The advent of computed tomography has brought about a remarkable improvement in accuracy of pre-operative staging in such cases by non-invasive means. The role of computed tomography in staging of renal cell carcinoma has been evaluated in 28 cases and correlated with clinical and surgical findings.

The diagnosis and local staging of renal cancer--an appraisal

The standard pattern of investigation for renal masses usually involves excretion urography, ultrasonography and angiography. This study was undertaken to determine whether computed tomography (CT) and fine needle aspiration cytology could provide information that might allow this pattern to be modified. Diagnostic information was obtained by needle aspiration cytology in 25 patients who were shown at operation to have a neoplasm. The diagnosis was correct in 22 cases (88%). By comparison, arteriography was accurate in 22 out of 24 (92%), and computed tomography provided the correct diagnosis in 19 out of 21 (90%). Staging was performed surgically and histologically in 21 patients, and when this was compared with the results of CT staging there was complete agreement in 13 cases (62%). A literature review revealed an average staging accuracy for CT of 81% while arteriography was accurate in only 57%. Thus CT appears to be as good as arteriography for diagnosis and potentially better for local staging. It is also less invasive, rapid and cost effective and could supersede arteriography as the primary diagnostic and staging investigation in patients with a solid renal mass.

Dynamic CT of the urogenital tract

The theoretical basis for and the technique of intravenous contrast enhancement by bolus injection for dynamic CT examination of the kidney are described. The clinical applications of this method include the study of normal vascular anatomy of the kidney, congenital kidney abnormalities and form variants, space-occupying lesions, and kidney trauma. In tumoral lesions of the kidney, dynamic CT aids in detecting the lesion as well as in the tumor staging and evaluating operability. CT time density curves can be used to study disturbances in renal perfusion, but the clinical value of this method needs further confirmation.

Absorbed doses at CT of the kidneys and at urography

Radiation doses to the skin, ovaries and testes were measured at urography and CT examinations of the kidneys and adrenals. The absorbed dose to the breasts and bone marrow at CT was estimated as well as the mean bone marrow dose at urography. The results were compared with previous measurements of absorbed doses and energy imparted at abdominal angiography including nephroangiography. CT of the kidneys involves a considerably lower risk for late biologic effects to the patient than urography and, in particular, angiography.